NEW YORK (GenomeWeb News) - Rosetta Genomics and New York University Medical Center said today that they plan to co-develop diagnostic tests for lung and mesothelioma cancers.
 
The early-detection tests will use Rosetta's technology for extracting microRNA from blood.
 
The tests will identify patients at risk of lung cancer due to smoking as well as those who have been exposed to asbestos fibers.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.